[1] RuizArgüelles GJ, RuizDelgado GJ, GarcesEisele J, et al. Donor cell leukemia after nonmyeloablative allogeneic stem cell transplantation: a single institution experience[J]. Leuk Lymphoma, 2006, 47(9): 1952-1955. DOI: 10.1080/10428190600693099.
[2] Wiseman DH. Donor cell leukemia: a review[J]. Biol Blood Marrow Transplant, 2011, 17(6): 771-789. DOI: 10.1016/j.bbmt.2010.10.010.
[3] RuizDelgado GJ, HernándezReyes J, GonzálezRamírez MP, et al. Donor cell leukemia (DCL): a prospective study of its identification and treatment[J]. Gac Med Mex, 2015, 151(5): 582-587.
[4] Wang E, Hutchinson CB, Huang Q, et al. Donor cellderived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature[J]. Am J Clin Pathol, 2011, 135(4): 525-540. DOI: 10.1309/AJCPPJUQ9DNR1GHP. |